Active immunoprophyilaxis with uromune® decreases the recurrence of urinary tract infections at three and six months after treatment without relevant secondary effects

Active immunoprophyilaxis with uromune® decreases the recurrence of urinary tract infections at three and six months after treatment without relevant secondary effects

Abstract Background To prospectively analyze the efficacy of uromune® in the prevention of uncomplicated recurrent urinary tract infections at 3 and 6 months, and according to gender and menopause. Methods From September 2011 to December 2017 uromune® was administered sublingually every 24 h along 3...

Full description

Bibliographic Details
Main Authors: Cristóbal Ramírez Sevilla, Esther Gómez Lanza, Juan Llopis Manzanera, Jose Antonio Romero Martín, Miguel Ángel Barranco Sanz
Format: Article
Language:English
Published: BMC 2019-10-01
Series:BMC Infectious Diseases
Subjects:
Urinary tract infection
Prevention
Bacterial vaccine
Online Access:http://link.springer.com/article/10.1186/s12879-019-4541-y

Internet

http://link.springer.com/article/10.1186/s12879-019-4541-y

Similar Items